S&P 5007,482.58▼0.3% Nasdaq25,870.65▲0.2% Dow52,348.09▼1.1% Russell 2K2,948.91▼1.1% 10-Yr4.57%+4bp VIX16.86+0.73 WTI$74.03▲5.1% Gold$4,091.40▼1.3% EUR/USD1.143▼0.1% BTC$63,168▲1.5% Nikkei68,257▼2.1%
At close · Thu, Jul 9, 2026
Daily Market Updates.

Earnings

Home›Earnings›Previews›AstraZeneca shares fall after heart drug trial misses…

AstraZeneca shares fall after heart drug trial misses target

Reported · Written up by our desk · Previews

AstraZeneca shares dropped sharply, falling about 9%, after a heart drug trial missed its target, CNBC Markets reported.

← Newer storyYen stays near 40-year lows amid lingering intervention risk

More like this

EarningsKeyBanc downgrades Salesforce amid doubts about AI narrative
EarningsAstraZeneca shares fall after heart drug trial misses primary endpoint
EarningsAirline earnings head into the next earnings cycle
EarningsDrugmaker sheds $27 billion in market value after failed trial
EarningsFedEx Freight discusses results on its first earnings call as a standalone

Sources

CNBC MarketsAstraZeneca stock dives 9% after heart drug trial misses target
CNBC WorldAstraZeneca stock dives 9% after heart drug trial misses target

Get the close, explained.

One email every trading day: what moved, why it moved, and what's on deck tomorrow. Read in 3 minutes.

Free. Unsubscribe anytime.